Successful radiofrequency ablation of liver metastases from prostate cancer

INTRODUCTION: Patients with liver metastases from prostate cancer show poor prognosis. We performed metastases‐directed therapy using radiofrequency ablation of liver metastases in an attempt to improve the prognosis in a patient with metastatic prostate cancer. CASE PRESENTATION: We present the cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Hino, Daichi, Sugano, Takahiro, Kino, Mika, Nakata, Takako, Kito, Hiroki, Inoue, Masafumi, Fujie, Hajime, Akakura, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626322/
https://www.ncbi.nlm.nih.gov/pubmed/36341188
http://dx.doi.org/10.1002/iju5.12513
_version_ 1784822704321331200
author Hino, Daichi
Sugano, Takahiro
Kino, Mika
Nakata, Takako
Kito, Hiroki
Inoue, Masafumi
Fujie, Hajime
Akakura, Koichiro
author_facet Hino, Daichi
Sugano, Takahiro
Kino, Mika
Nakata, Takako
Kito, Hiroki
Inoue, Masafumi
Fujie, Hajime
Akakura, Koichiro
author_sort Hino, Daichi
collection PubMed
description INTRODUCTION: Patients with liver metastases from prostate cancer show poor prognosis. We performed metastases‐directed therapy using radiofrequency ablation of liver metastases in an attempt to improve the prognosis in a patient with metastatic prostate cancer. CASE PRESENTATION: We present the case of a 66‐year‐old man who was treated for metastatic castration‐resistant prostate cancer. Evaluation showed isolated liver metastases together with elevated serum prostate‐specific antigen levels. We performed metastases‐directed therapy using radiofrequency ablation of the liver tumor. The patient showed no recurrent liver metastases for 42 months and survived for 66 months after diagnosis of metastatic prostate cancer. CONCLUSION: To our knowledge, this is the first report that describes radiofrequency ablation of liver metastases from prostate cancer. This procedure may be a useful therapeutic option for metastases‐directed therapy in patients with liver metastases from prostate cancer.
format Online
Article
Text
id pubmed-9626322
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96263222022-11-03 Successful radiofrequency ablation of liver metastases from prostate cancer Hino, Daichi Sugano, Takahiro Kino, Mika Nakata, Takako Kito, Hiroki Inoue, Masafumi Fujie, Hajime Akakura, Koichiro IJU Case Rep Case Reports INTRODUCTION: Patients with liver metastases from prostate cancer show poor prognosis. We performed metastases‐directed therapy using radiofrequency ablation of liver metastases in an attempt to improve the prognosis in a patient with metastatic prostate cancer. CASE PRESENTATION: We present the case of a 66‐year‐old man who was treated for metastatic castration‐resistant prostate cancer. Evaluation showed isolated liver metastases together with elevated serum prostate‐specific antigen levels. We performed metastases‐directed therapy using radiofrequency ablation of the liver tumor. The patient showed no recurrent liver metastases for 42 months and survived for 66 months after diagnosis of metastatic prostate cancer. CONCLUSION: To our knowledge, this is the first report that describes radiofrequency ablation of liver metastases from prostate cancer. This procedure may be a useful therapeutic option for metastases‐directed therapy in patients with liver metastases from prostate cancer. John Wiley and Sons Inc. 2022-08-05 /pmc/articles/PMC9626322/ /pubmed/36341188 http://dx.doi.org/10.1002/iju5.12513 Text en © 2022 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Hino, Daichi
Sugano, Takahiro
Kino, Mika
Nakata, Takako
Kito, Hiroki
Inoue, Masafumi
Fujie, Hajime
Akakura, Koichiro
Successful radiofrequency ablation of liver metastases from prostate cancer
title Successful radiofrequency ablation of liver metastases from prostate cancer
title_full Successful radiofrequency ablation of liver metastases from prostate cancer
title_fullStr Successful radiofrequency ablation of liver metastases from prostate cancer
title_full_unstemmed Successful radiofrequency ablation of liver metastases from prostate cancer
title_short Successful radiofrequency ablation of liver metastases from prostate cancer
title_sort successful radiofrequency ablation of liver metastases from prostate cancer
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626322/
https://www.ncbi.nlm.nih.gov/pubmed/36341188
http://dx.doi.org/10.1002/iju5.12513
work_keys_str_mv AT hinodaichi successfulradiofrequencyablationoflivermetastasesfromprostatecancer
AT suganotakahiro successfulradiofrequencyablationoflivermetastasesfromprostatecancer
AT kinomika successfulradiofrequencyablationoflivermetastasesfromprostatecancer
AT nakatatakako successfulradiofrequencyablationoflivermetastasesfromprostatecancer
AT kitohiroki successfulradiofrequencyablationoflivermetastasesfromprostatecancer
AT inouemasafumi successfulradiofrequencyablationoflivermetastasesfromprostatecancer
AT fujiehajime successfulradiofrequencyablationoflivermetastasesfromprostatecancer
AT akakurakoichiro successfulradiofrequencyablationoflivermetastasesfromprostatecancer

Ejemplares similares